BMJ Best Practice

参考文献

关键文献

Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 2002;15:145-154.

Juranek DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis. 1995;21(suppl 1):S57-S61.

Farthing MJ. Clinical aspects of human cryptosporidiosis. In: Petry F, ed. Cryptosporidiosis and microsporidiosis. Contributions in microbiology. Karger, Basel: 2000;6:50-74.

MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis. 1995;21:57-62.

Centers for Disease Control and Prevention. Cryptosporidiosis (Cryptosporidium spp.): 2012 case definition. February 2015. http://cdc.gov (last accessed 11 August 2017).

Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis. 2001;184:103-106.

Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. December 2016. https://aidsinfo.nih.gov (last accessed 11 August 2017).

Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. August 2017. http://aidsinfo.nih.gov/ (last accessed 11 August 2017).

参考文章

1.  Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 2002;15:145-154.

2.  Chalmers RM, Davies AP. Mini-review: Clinical cryptosporidiosis. Exp Parasitol. 2010;121:138-146.

3.  Barta JR, Thompson RC. What is Cryptosporidium? Reappraising its biology and phylogenetic affinities. Trends Parasitol. 2006;22:463-468.

4.  Fayer R. Taxonomy and species delimitation in Cryptosporidium. Exp Parasitol. 2010;124:90-97.

5.  Chalmers RM, Robinson G, Elwin K, et al. Cryptosporidium sp. rabbit genotype, a newly identified human pathogen. Emerg Infect Dis. 2009;15:829-830.

6.  Cama VA, Bern C, Roberts J, et al. Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis. 2008;14:1567-1574.

7.  Manabe YC, Clark DP, Moore RD, et al. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis. 1998;27:536-542.

8.  Pettoello-Mantovani M, Di Martino L, Dettori G, et al. Asymptomatic carriage of intestinal Cryptosporidium immunocompetent and immunodeficient children: a prospective study. Pediatr Infect Dis J. 1995;14:1042-1047.

9.  Isaacs D, Hunt GH, Phillpis AD, et al. Cryptosporidiosis in immunocompentent children. J Clin Pathol. 1985;38:76-81.

10.  Baxby D, Hart CA. The incidence of cryptosporidiosis: a two-year prospective survey in a children's hospital. J Hyg (Lond). 1986;96:107-111.

11.  Addiss DG, Stewart JM, Finton RJ, et al. Giardia lamblia and Cryptosporidium infections in child day-care centers in Fulton County, Georgia. Pediatr Infect Dis J. 1991;10:907-911.

12.  García-Rodríguez JA, Martín-Sánchez AM, Canut Blasco A, et al. The prevalence of Cryptosporidium species in children in day care centres and primary schools in Salamanca (Spain): an epidemiological study. Eur J Epidemiol. 1990;6:432-435.

13.  Davies AP, Campbell B, Evans MR, et al. Asymptomatic carriage of protozoan parasites in children in day care centers in the United Kingdom. Pediatr Infect Dis J. 2009;28:838-840.

14.  Lacroix C, Berthier M, Agius G, et al. Cryptosporidium oocysts in immunocompetent children: epidemiologic investigations in the day-care centers of Poitiers, France. Eur J Epidemiol. 1987;3:381-385.

15.  Sallon S, Deckelbaum RJ, Schmid II, et al. Cryptosporidium, malnutrition, and chronic diarrhea in children. Am J Dis Child. 1988;142:312-315.

16.  Sarabia-Arce S, Salazar-Lindo E, Gilman RH, et al. Case-control study of Cryptosporidium parvum infection in Peruvian children hospitalized for diarrhea: possible association with malnutrition and nosocomial infection. Pediatr Infect Dis J. 1990;9:627-631.

17.  Lima AA, Fang G, Schorling JB, et al. Persistent diarrhea in Northeast Brazil: etiologies and interactions with malnutrition. Acta Paediatr Suppl. 1992;381:39-44.

18.  Mølbak K, Andersen M, Aaby P, et al. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, west Africa. Am J Clin Nutr. 1997;65:149-152.

19.  Checkley W, Epstein LD, Gilman RH, et al. Effects of Cryptosporidium parvum in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol. 1998;148:497-506.

20.  Adak GK, Long SM, O'Brien SJ. Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut. 2002;51:832-841.

21.  Yoder JS, Beach MJ. Centers for Disease Control and Prevention (CDC). Cryptosporidiosis surveillance - United States, 2003-2005. MMWR Surveill Summ. 2007;56:1-10.

22.  Yoder JS, Wallace RM, Collier SA, et al; Centers for Disease Control and Prevention (CDC). Cryptosporidiosis surveillance - United States, 2009-2010. MMWR Surveill Summ. 2012;61:1-12.

23.  Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382:209-222.

24.  Hunter PR, Hughes S, Woodhouse S, et al. Sporadic cryptosporidiosis case-control study with genotyping. Emerg Infect Dis. 2004;10:1241-1249.

25.  Chalmers RM, Elwin K, Thomas AL, et al. Long-term Cryptosporidium typing reveals the aetiology and species-specific epidemiology of human cryptosporidiosis in England and Wales, 2000 to 2003. Euro Surveill. 2009;14:19086.

26.  Fayer R. General biology. In: Fayer R, Xiao L, eds. Cryptospsoridium and cryptosporidiosis. Boca Raton, FL: CRC Press; 2008:1-42.

27.  Juranek DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis. 1995;21(suppl 1):S57-S61.

28.  Clayton F, Heller T, Kotler DP. Variation in the enteric distribution of cryptosporidia in acquired immunodeficiency syndrome. Am J Clin Path. 1994;102:420-425.

29.  Berk RN, Wall SD, McArdle CB, et al. Cryptosporidiosis of the stomach and small intestine in patients with AIDS. AJR Am J Roentgenol. 1984;143:549-554.

30.  Meisel JL, Perera DR, Meligro C, et al. Overwhelming watery diarrhea associated with a Cryptosporidium in an immunosuppressed patient. Gastroenterology. 1976;70:1156-1160.

31.  Farthing MJ. Clinical aspects of human cryptosporidiosis. In: Petry F, ed. Cryptosporidiosis and microsporidiosis. Contributions in microbiology. Karger, Basel: 2000;6:50-74.

32.  Guarino A, Canani RB, Pozio E, et al. Enterotoxic effect of stool supernatant of Cryptosporidium-infected calves on human jejunum. Gastroenterology. 1994;106:28-34.

33.  Guarino A, Canani RB, Casola A, et al. Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. J Infect Dis. 1995;171:976-983.

34.  Laurent F, Eckmann L, Savidge TC, et al. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemikines. Infect Immun. 1997;65:5067-5073.

35.  McDonald V, Smith R, Robinson H, et al. Host immune responses against Cryptosporidium. Contrib Microbiol. 2000;6:75-91.

36.  Argenzio RA, Liacos JA, Levy ML, et al. Villous atrophy, crypt hyperplasia, cellular infiltration, and impaired glucose-Na absorption in enteric cryptosporidiosis of pigs. Gastroenterology. 1990;98:1129-1140.

37.  Kirkpatrick BD, Noel F, Rouzier PD, et al. Childhood cryptosporidiosis is associated with a persistent systemic inflammatory response. Clin Infect Dis. 2006;43:604-608.

38.  Lumadue JA, Manabe YC, Moore RD, et al. A clinicopathologic analysis of AIDS-related cryptosporidiosis. AIDS. 1998;12:2459-2466.

39.  Bonacini M. Hepatobiliary complications in patients with human immunodeficiency virus infection. Am J Med. 1992;92:404-411.

40.  Benhamou Y, Caumes E, Gerosa Y, et al. AIDS-related cholangiopathy: critical analysis of a prospective series of 26 patients. Dig Dis Sci. 1993;38:1113-1118.

41.  Chen XM, Levine SA, Tietz P, et al. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology. 1998;28:906-913.

42.  Chen XM, Gores GJ, Paya CV, et al. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am J Physiol. 1999;277:G599-G608.

43.  Davis JJ, Heyman MB, Ferrell L, et al. Sclerosing cholangitis associated with chronic cryptosporidiosis in a child with congenital immunodeficiency disorder. Am J Gastroenterol. 1987;82:1196-1202.

44.  Dowsett JF, Miller R, Davidson R, et al. Sclerosing cholangitis in acquired immunodeficiency syndrome: case reports and review of the literature. Scand J Gastroenterol. 1988;23:1267-1274.

45.  Cello JP. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med. 1989;86:539-546.

46.  Chen XM, LaRusso NF. Cryptosporidiosis and the pathogenesis of AIDS-cholangiopathy. Semin Liver Dis. 2002;22:277-289.

47.  McLauchlin J, Amar CF, Pedraza-Díaz S, et al. Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficiencies. Pediatr Infect Dis J. 2003;22:329-335.

48.  Clavel A, Arnal AC, Sánchez EC, et al. Respiratory cryptosporidiosis: case series and review of the literature. Infection. 1996;24:341-346.

49.  Dunand VA, Hammer SM, Rossi R, et al. Parasitic sinusitis and otitis in patients infected with human immunodeficiency virus: report of five cases and review. Clin Infect Dis. 1997;25:267-272.

50.  Robertson B, Sinclair MI, Forbes AB, et al. Case control studies of sporadic cryptosporidiosis in Melbourne and Adelaide, Australia. Epidemiol Infect. 2002;28:419-431.

51.  Pritchard GC, Fleetwood AJ. Cryptosporidiosis and farm visits. Vet Rec. 1995;136:179.

52.  Centers for Disease Control and Prevention. Parasites - Cryptosporidium (also known as "Crypto"): Sources of infection and risk factors. April 2015. http://www.cdc.gov (last accessed 11 August 2017).

53.  Cordell RL, Addiss DG. Cryptosporidiosis in child care settings: a review of the literature and recommendations for prevention and control. Pediatr Infect Dis J. 1994;13:310-317.

54.  Centers for Disease Control and Prevention (CDC). Cryptosporidiosis outbreaks associated with recreational water use - five states, 2006. MMWR Morb Mortal Wkly Rep. 2007;56:729-732.

55.  Centers for Disease Control and Prevention (CDC). Outbreak of cryptosporidiosis associated with a splash park - Idaho, 2007. MMWR Morb Mortal Wkly Rep. 2009;58:615-618.

56.  Centers for Disease Control and Prevention (CDC). Communitywide cryptosporidiosis outbreak - Utah, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:989-993.

57.  MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis. 1995;21:57-62.

58.  Flanigan T, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 counts. Ann Intern Med. 1992;116:840-842.

59.  Blanshard C, Jackson AM, Shanson DC, et al. Cryptosporidiosis in HIV-seropositive patients. Q J Med. 1992;85:813-823.

60.  Navin TR, Weber R, Vugia DJ, et al. Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:154-159.

61.  Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001 Feb 1;32(3):331-51.

62.  Garcia LS. Diagnostic medical parasitology. 5th ed. Washington DC: ASM Press; 2007.

63.  Doing KM, Hamm JL, Jellison JA, et al. False-positive results obtained with the Alexon ProSpecT Cryptosporidium enzyme immunoassay. J Clin Microbiol. 1999;37:1582-1583.

64.  Public Health Laboratory Service Study Group. Cryptosporidiosis in England and Wales: prevalence and clinical and epidemiological features. BMJ. 1990;300:774-777.

65.  Centers for Disease Control and Prevention. Cryptosporidiosis (Cryptosporidium spp.): 2012 case definition. February 2015. http://cdc.gov (last accessed 11 August 2017).

66.  Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis. 2001;184:103-106.

67.  Diaz E, Mondragon J, Ramirez E, et al. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg. 2003;68:384-385.

68.  Favennec L, Jave Ortiz J, Gargala G, et al. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Aliment Pharmacol Ther. 2003;17:265-270.

69.  Doumbo O, Rossignol JF, Pichard E, et al. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa. Am J Trop Med Hyg. 1997;56:637-639.

70.  Hommer V, Eichholz J, Petry F. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum. J Antimicrob Chemother. 2003;52:359-364.

71.  Abdo A, Klassen J, Urbanski S, et al. Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient. J Hepatol. 2003;38:688-691.

72.  Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. December 2016. https://aidsinfo.nih.gov (last accessed 11 August 2017).

73.  Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. August 2017. http://aidsinfo.nih.gov/ (last accessed 11 August 2017).

74.  Rossignol JF, Hidalgo H, Feregrino M, et al. A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg. 1998;92:663-666.

75.  White AC Jr, Chappell CL, Hayat CS, et al. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis. 1994;170:419-424.

76.  Bissuel F, Cotte L, Rabodonirina M, et al. Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clin Infect Dis. 1994;18:447-449.

77.  Hewitt RG, Yiannoutsos CT, Higgs ES, et al. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. Clin Infect Dis. 2000;31:1084-1092.

78.  Kadappu KK, Nagaraja MV, Rao PV, et al. Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. J Postgrad Med. 2002;48:179-181.

79.  Allam AF, Shehab AY. Efficacy of azithromycin, praziquantel and mirazid in treatment of cryptosporidiosis in school children. J Egypt Soc Parasitol. 2002;32:969-978.

80.  Russell TS, Lynch J, Ottolini MG. Eradication of Cryptosporidium in a child undergoing maintenance chemotherapy for leukemia using high dose azithromycin therapy. J Pediatr Hematol Oncol. 1998;20:83-85.

81.  Blanshard C, Shanson DC, Gazzard BG. Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis. Int J STD AIDS. 1997;8:124-129.

82.  Palmieri F, Cicalini S, Froio N, et al. Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycin. Int J STD AIDS. 2005;16:515-517.

83.  Smith NH, Cron NS, Valdez LM, et al. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis. 1998;178:900-903.

84.  Hunter PR, Hughes S, Woodhouse S, et al. Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin Infect Dis. 2004;39:504-510.

85.  Hay EM, Winfield J, McKendrick MW. Reactive arthritis associated with Cryptosporidium enteritis. Br Med J (Clin Res Ed). 1987;295:248.

86.  Ozgül A, Tanyüksel M, Yazicioglu K, et al. Sacroiliitis associated with Cryptosporidium parvum in an HLA-B27-negative patient. Rheumatology. 1999;38:288-289.

87.  Cron RQ, Sherry DD. Reiter's syndrome associated with cryptosporidial gastroenteritis. J Rheumatol. 1995;22:1962-1963.

88.  Shepherd RC, Smail PJ, Sinha GP. Reactive arthritis complicating cryptosporidial infection. Arch Dis Child. 1989;64:743-744.

使用此内容应接受我们的免责声明